Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transition metal ions, primarily iron (Fe2+) and copper (Cu+), are the central catalysts in Fenton and Fenton-like chemistry, where they react with hydrogen peroxide to generate the highly reactive hydroxyl radical (.OH) (Winterbourn, 1995, Toxicology Letters). This process is a major source of oxidative stress within cells, as hydroxyl radicals cause non-specific damage to DNA, proteins, and membrane lipids through lipid peroxidation (Wardman & Candeias, 1996, Radiation Research). Under physiological conditions, these metals are sequestered by storage and transport proteins like ferritin and transferrin to prevent unwanted redox activity. However, in various disease states, the labile metal pool increases, leading to pathological oxidative damage and the induction of ferroptosis, a form of regulated cell death (Dixon & Stockwell, 2014, Nature Chemical Biology). Therapeutic targeting of these ions typically involves chelation therapy, using drugs like deferoxamine or deferiprone to sequester the metals and prevent their participation in radical-generating reactions (Kontoghiorghes et al., 2004, Current Medicinal Chemistry). This approach is vital in treating iron overload disorders, Wilson's disease, and is being investigated for neurodegenerative and cardiovascular conditions (Jomova & Valko, 2011, Toxicology).
Chelation and sequestration of redox-active metal ions to prevent the formation of reactive oxygen species (ROS) via Fenton and Fenton-like reactions.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transition metal ions involved in Fenton chemistry.